Insilico Medicine and Bora Pharmaceuticals lreveal plans for an AI-driven biologics manufacturing venture, forecast to be worth over $2.5B.

Insilico Medicine and Bora Pharmaceuticals lreveal plans for an AI-driven biologics manufacturing venture, forecast to be worth over $2.5B.

Red-hot generative AI specialist Insilico Medicine has teamed up with another major biopharma player, this time linking up with CDMO Bora Pharmaceuticals. | Generative AI…